Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Resveratrol As an Adjuvant for Normal Tissues Protection and Tumor Sensitization Publisher Pubmed



Mortezaee K1 ; Najafi M2 ; Farhood B3 ; Ahmadi A4 ; Shabeeb D5 ; Musa AE6
Authors

Source: Current Cancer Drug Targets Published:2020


Abstract

Cancer is one of the most complicated diseases in present-day medical science. Yearly, several studies suggest various strategies for preventing carcinogenesis. Furthermore, experiments for the treatment of cancer with low side effects are ongoing. Chemotherapy, targeted therapy, radiotherapy and immunotherapy are the most common non-invasive strategies for cancer treatment. One of the most challenging issues encountered with these modalities is low effectiveness, as well as normal tissue toxicity for chemo-radiation therapy. The use of some agents as adjuvants has been suggested to improve tumor responses and also alleviate normal tissue toxicity. Resveratrol, a natural flavonoid, has attracted a lot of attention for the management of both tumor and normal tissue responses to various modalities of cancer therapy. As an antioxidant and anti-inflammatory agent, in vitro and in vivo studies show that it is able to mitigate chemo-radiation toxicity in normal tissues. However, clinical studies to confirm the usage of resveratrol as a chemo-radioprotector are lacking. In addition, it can sensitize various types of cancer cells to both chemotherapy drugs and radiation. In recent years, some clinical studies suggested that resveratrol may have an effect on inducing cancer cell killing. Yet, clinical translation of resveratrol has not yielded desirable results for the combination of resveratrol with radiotherapy, targeted therapy or immunotherapy. In this paper, we review the potential role of resveratrol for preserving normal tissues and sensitization of cancer cells in combination with different cancer treatment modalities. © 2020 Bentham Science Publishers.
Other Related Docs
6. Immunoregulation by Resveratrol; Implications for Normal Tissue Protection and Tumour Suppression, Clinical and Experimental Pharmacology and Physiology (2023)
9. Resveratrol As an Enhancer of Apoptosis in Cancer: A Mechanistic Review, Anti-Cancer Agents in Medicinal Chemistry (2021)
15. Targets for Protection and Mitigation of Radiation Injury, Cellular and Molecular Life Sciences (2020)
16. Selenium As an Adjuvant for Modification of Radiation Response, Journal of Cellular Biochemistry (2019)